LOXO Announces Receipt of Breakthrough Therapy Designation

LOXO: Loxo Oncology, Inc.
2018-09-05 06:45:00
Loxo Oncology Announces Receipt of Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-292